1. Home
  2. SAMG vs ABOS Comparison

SAMG vs ABOS Comparison

Compare SAMG & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercrest Asset Management Group Inc.

SAMG

Silvercrest Asset Management Group Inc.

HOLD

Current Price

$14.47

Market Cap

112.1M

Sector

Finance

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$1.85

Market Cap

113.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAMG
ABOS
Founded
2002
1996
Country
United States
United States
Employees
164
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.1M
113.9M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
SAMG
ABOS
Price
$14.47
$1.85
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
31.8K
172.5K
Earning Date
10-30-2025
11-12-2025
Dividend Yield
6.15%
N/A
EPS Growth
N/A
N/A
EPS
0.72
N/A
Revenue
$125,322,000.00
N/A
Revenue This Year
$4.23
N/A
Revenue Next Year
$7.48
N/A
P/E Ratio
$18.99
N/A
Revenue Growth
4.23
N/A
52 Week Low
$13.23
$0.86
52 Week High
$19.20
$2.46

Technical Indicators

Market Signals
Indicator
SAMG
ABOS
Relative Strength Index (RSI) 60.06 49.78
Support Level $13.32 $1.51
Resistance Level $13.79 $2.03
Average True Range (ATR) 0.38 0.15
MACD 0.12 0.02
Stochastic Oscillator 100.00 63.89

Price Performance

Historical Comparison
SAMG
ABOS

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: